Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Postoperative Cyclic Oral Contraceptive Use After Gonadotropin-releasing Hormone Agonist for the Prevention of Endometrioma Recurrence

NCT01092494 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01092494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01092494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Postoperative Cyclic Oral Contraceptive Use After Gonadotropin-releasing Hormone Agonist for the Prevention of Endometrioma Recurrence
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2010
Completion date
March 31, 2010
Enrollment
232 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis